SHWM
EDIT icon

Silicon Hills Wealth Management’s Editas Medicine EDIT Stock Holding History

Silicon Hills Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10,000
Closed -$72.5K – 85
2023
Q1 		$72.5K Hold
10,000
– – 0.04% 84
2022
Q4 		$88.7K Buy
+10,000
New +$110K 0.07% 93

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Silicon Hills Wealth Management's EDIT Position: Q2 2023 in Review

Silicon Hills Wealth Management sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 10,000 shares — an estimated $72.5K sold.

Silicon Hills Wealth Management first reported a position in EDIT in Q4 2022 and held it in 2 quarters. The position peaked at $88.7K in Q4 2022. 238 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

  • Silicon Hills Wealth Management reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
  • Silicon Hills Wealth Management sold 10,000 Editas Medicine shares in Q2 2023, an estimated $72.5K.
  • Silicon Hills Wealth Management first reported a position in Editas Medicine in Q4 2022 and held it in 2 quarters.
  • Silicon Hills Wealth Management's Editas Medicine position peaked at $88.7K in Q4 2022.
  • 238 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on Silicon Hills Wealth Management's 13F filing for Q2 2023, filed 14 Aug 2023.